Related Experiment Video
Updated: Nov 9, 2025

Protocol to Create Chronic Wounds in Diabetic Mice
Published on: September 25, 2019
Long-term Mortality among Patients with Chronic Ulcers
Jenni E Salenius1, Minna Suntila, Tiina Ahti
1Department of Dermatology, Tampere University Hospital, Central Hospital, PO Box 2000, FIN-33521 Tampere, Finland.
Patients with chronic ulcers face a significantly higher long-term mortality risk. Diabetes and sepsis were major contributing factors to death in this patient group.
Area of Science:
- Dermatology
- Public Health
- Epidemiology
Background:
- Chronic ulcers represent a substantial global health burden.
- Understanding long-term mortality associated with chronic ulcers is crucial for patient care and resource allocation.
Purpose of the Study:
- To evaluate long-term mortality risk in patients diagnosed with chronic ulcers.
- To identify underlying and immediate causes of death in this cohort.
- To examine factors influencing mortality risk, including ulcer type.
Main Methods:
- A retrospective cohort study comparing 3,489 patients with chronic ulcers to 10,399 matched controls.
- Data collected from a dermatology clinic between 1980 and 2010.
- Statistical analysis using hazard ratios (HR) to assess mortality risk and associated factors.
Main Results:
- Patients with chronic ulcers exhibited a 1.74-fold increased mortality risk compared to controls.
- Diabetes (HR 8.98) and sepsis (HR 5.86) were significantly associated with mortality.
- Increased mortality risk was observed across all ulcer types, notably arterial ulcers (HR 2.85).
Conclusions:
- Chronic ulcer patients face elevated long-term mortality regardless of age, sex, or ulcer etiology.
- Effective management of underlying conditions like diabetes and prevention of sepsis are critical.
- Further research into specific ulcer types may reveal targeted interventions to mitigate mortality risk.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...

